| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | dabrafenib | GDSC1000 | pan-cancer | AAC | 0.12 | 5e-05 |
| mRNA | THZ-2-49 | GDSC1000 | pan-cancer | AAC | -0.12 | 7e-05 |
| mRNA | Bleomycin | GDSC1000 | pan-cancer | AAC | -0.13 | 0.0003 |
| mRNA | Tamoxifen | GDSC1000 | pan-cancer | AAC | 0.13 | 0.0003 |
| mRNA | salermide:PLX-4032 (12:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0004 |
| mRNA | XMD11-85h | GDSC1000 | pan-cancer | AAC | 0.17 | 0.0004 |
| mRNA | dabrafenib | CTRPv2 | pan-cancer | AAC | 0.17 | 0.0006 |
| mRNA | PLX4720 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.0006 |
| mRNA | Vinblastine | GDSC1000 | pan-cancer | AAC | -0.12 | 0.0007 |
| mRNA | Irinotecan | gCSI | pan-cancer | AAC | -0.19 | 0.0008 |